Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21106299 | 0.97 | GAA (0.36) | ALDH1A1KDM4EHSD17B10GAAPKM | |
| SCHEMBL24029420 | 0.97 | GAA (0.36) | ALDH1A1KDM4EHSD17B10GAAPKM | |
| SCHEMBL22525803 | 0.97 | GAA (0.36) | ALDH1A1KDM4EHSD17B10GAAPKM | |
| SCHEMBL17540070 | 0.86 | ALDH1A1 (0.36) | ALDH1A1KDM4EHSD17B10GAAPKM | |
| SCHEMBL17465663 | 0.80 | KDM4E (0.31) | ALDH1A1KDM4EHSD17B10GAAPKM | |
| SCHEMBL27273679 | 0.75 | GAA (0.32) | GAAPKMTDP1 | |
| SCHEMBL23560395 | 0.75 | GAA (0.31) | GAAPKMTDP1 | |
| SCHEMBL22802952 | 0.75 | GAA (0.31) | GAAPKMTDP1 | |
| SCHEMBL13245100 | 0.72 | — | — | |
| SCHEMBL14408499 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160289566-A1 | SULFENAMIDES AS FLAME RETARDANTS | SONGWON INTERNATIONAL AG (CH) | 2016-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289566-A1 | SULFENAMIDES AS FLAME RETARDANTS | STS, TST, PFAS | ALDH1A1 430/4885KDM4E 870/4885HSD17B10 590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.